| Enrollment | Allocation | Post-allocation | |||
---|---|---|---|---|---|---|
Eligibility T0 | Baseline T1 | Sessions 1–4 | Post-Session T2 | 3 Months T3 | 6 Months T4 | |
ENROLLMENT | ||||||
 Eligibility screen | X |  |  |  |  |  |
 Informed consent |  | X |  |  |  |  |
 Allocation |  | X |  |  |  |  |
INTERVENTIONS | ||||||
 IE intervention |  |  | X |  |  |  |
 LHT intervention |  |  | X |  |  |  |
MEASURES | ||||||
Primary outcome | ||||||
 Female Sexual Function Index   (FSFI)a |  | X |  | X | X | X |
Secondary outcomes | ||||||
 Male partners: International Index of Erectile Function (IIEF)  Female partners: FSFI |  | X |  | X | X | X |
 Female Sexual Distress Scale- Revised (FSDS-R)a |  | X |  | X | X | X |
 Miller Social Intimacy Scale (MSIS) |  | X |  | X | X | X |
 Dyadic Adjustment Scale-7 item (DAS-7) |  | X |  | X | X | X |
 Patient Health Questionnaire-9 item (PHQ-9) |  | X |  | X | X | X |
 Generalized Anxiety Disorder 7-item (GAD-7) |  | X |  | X | X | X |
Mediators | ||||||
 Dyadic Sexual Communication Scale (DSCS)a |  | X |  | X |  |  |
 Self-efficacy (for coping with sexual concerns)a |  | X |  | X |  |  |